- email:registrations@informa-ls.com
- phone:+44(0)20 7017 7481
 |
Improving Comparator Studies
11 - 12 October 2011
|
Inaugural Improving Comparator Studies
Learn from industry experience on how to save money, increase efficiency and ensure compliance of your comparator studies
Key benefits of attending:
- Learn from an Ethics Committees perspective what they look for when reviewing comparator studies
- Discuss your regulatory questions with an MHRA representative in an interactive panel discussion
- Listen to 8 industry case studies bringing you practical advice when conducting your comparator studies
- Network with high level industry professionals from across the comparator studies and clinical trials supplies field at this co-located conference
- Explore the analytical approach to blinding strategies and stability testing for comparator products, include the use of over-encapsulation
- Find out how companies are implementing successfully comparator sourcing strategies
2011 Conference Highlights
Exciting topics for 2011 include:
-
Hear the latest regulatory expectations and perspectives from the MHRA
Discover the expectations of an Ethics Committees from the managing physician of an Ethics Commission
Learn from Boehringer Ingelheim, Pfizer and GlaxoSmithKline how they overcame the challenges faced in this area including the chance to discuss Central sourcing versus Local sourcing
Understand the role and requirements of a Qualified Person from Baxter and ensuring compliance to Good Manufacturing Practice
Gain a new perspective – hear from the experiences of a clinical investigator
Explore the essential analytical methods for blinding strategies and stability testing, including the use of over-encapsulation
Network with high level industry professionals from across the comparator studies and clinical trials supplies
Sponsors
Media Partners
Increased Networking Opportunities: This conference is co-located with
Expert Speaker Pannel
Expert Speaker Pannel
Prof. Malcolm Lader
Emeritus Professor of Clinical Psychopharmacology, Institute of Psychiatry
King’s College London
|
Ute Buhler
GMP analytics
Pfizer UK
|
- Peter Feldschreiber, Barrister, Four New Square, Lincolns Inn London, Senior Medical Assessor, MHRA
- Peter Orosz, Head of Clinical Supply Chain Management, Oncology, Boehringer Ingelheim
- Jeroze Dalal, Clinical Operations, GlaxoSmithKline
- Kati Mortier, Global Qualified Person,Johnson & Johnson PRD
- Denise Hager, Comparative Agent Development, Pfizer Inc.
- Niklas Mattsson, Independent Consultant
- Albert Chau, Data and Statistical Science Consultant, in2phase Limited
Don't miss our must-attend pre-workshop
Pre-Conference Workshop W - Monday 10 October
EMA, FDA and Clinical Supply Chain Management
Led by: Patti Seymour, BioProcess Technology Consultants, Inc.
Feeds | Like | Share    |
Dates and Venues
11 Oct 2011 - 12 Oct 2011
Ramada Plaza Basel Conference Center
Speaking opportunities still available
Please contact:
Michael Combellack
Conference Producer
Informa Life Sciences
Tel: +44 (0) 20 7017 5031
Email: michael.combellack@informa.com
Connect with me on LinkedIn!
http://www.linkedin.com/pub/michael-combellack/2a/ab1/90b
Who Should Attend?
Heads of Department, Directors, Managers, Team Leaders, Associates, Consultants and Coordinators from:
- Clinical Supplies
- Sourcing
- Clinical Development
- Analytical Development
- CMC and Analytical Chemistry
- Regulatory Affairs
- Clinical Operations
